Literature DB >> 17626094

Dengue virus (DV) replication in monocyte-derived macrophages is not affected by tumor necrosis factor alpha (TNF-alpha), and DV infection induces altered responsiveness to TNF-alpha stimulation.

Satiya Wati1, Peng Li, Christopher J Burrell, Jillian M Carr.   

Abstract

Tumor necrosis factor alpha (TNF-alpha) is believed to play a significant role in the pathogenesis of dengue virus (DV) infection, with elevated levels of TNF-alpha in the sera of DV-infected patients paralleling the severity of disease and TNF-alpha release being coincident with the peak of DV production from infected monocyte-derived macrophages (MDM) in vitro. Since macrophages are a primary cell target in vivo for DV infection, we investigated the potential antiviral role of TNF-alpha in regulating DV replication in MDM. While pretreatment of MDM with TNF-alpha had a minor inhibitory effect, addition of TNF-alpha to MDM with established DV infection had no effect on DV replication as measured by DV RNA levels or progeny virus production. Blocking endogenous TNF-alpha using short interfering RNA or inhibitory TNF-alpha antibodies also had no effect on infectious DV production or viral RNA synthesis. Together, these results demonstrate that DV replication in MDM is not affected by TNF-alpha. Additionally, normal cellular TNF-alpha signaling, measured by quantitation of TNF-alpha-induced stimulation of transcription from an NF-kappaB-responsive reporter plasmid or NF-kappaB protein nuclear translocation, was blocked in DV-infected MDM and Huh7 cells. Thus, DV replication in MDM is not affected by TNF-alpha, and infected cells do not respond normally to TNF-alpha stimulation. It is therefore unlikely that the increased production of TNF-alpha seen in DV infection directly effects DV clearance by reducing DV replication, and the ability of DV to alter TNF-alpha responsiveness highlights another example of viral subversion of cellular functions.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17626094      PMCID: PMC2045434          DOI: 10.1128/JVI.00313-07

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  57 in total

Review 1.  Rous-Whipple Award Lecture. Viruses, immunity, and cancer: lessons from hepatitis B.

Authors:  F V Chisari
Journal:  Am J Pathol       Date:  2000-04       Impact factor: 4.307

2.  Replication of dengue virus type 2 in human monocyte-derived macrophages: comparisons of isolates and recombinant viruses with substitutions at amino acid 390 in the envelope glycoprotein.

Authors:  M J Pryor; J M Carr; H Hocking; A D Davidson; P Li; P J Wright
Journal:  Am J Trop Med Hyg       Date:  2001-11       Impact factor: 2.345

3.  Infection of human dendritic cells by dengue virus causes cell maturation and cytokine production.

Authors:  L J Ho; J J Wang; M F Shaio; C L Kao; D M Chang; S W Han; J H Lai
Journal:  J Immunol       Date:  2001-02-01       Impact factor: 5.422

4.  Modulation of Dengue virus infection in human cells by alpha, beta, and gamma interferons.

Authors:  M S Diamond; T G Roberts; D Edgil; B Lu; J Ernst; E Harris
Journal:  J Virol       Date:  2000-06       Impact factor: 5.103

5.  Human dendritic cells are activated by dengue virus infection: enhancement by gamma interferon and implications for disease pathogenesis.

Authors:  D H Libraty; S Pichyangkul; C Ajariyakhajorn; T P Endy; F A Ennis
Journal:  J Virol       Date:  2001-04       Impact factor: 5.103

6.  Human skin Langerhans cells are targets of dengue virus infection.

Authors:  S J Wu; G Grouard-Vogel; W Sun; J R Mascola; E Brachtel; R Putvatana; M K Louder; L Filgueira; M A Marovich; H K Wong; A Blauvelt; G S Murphy; M L Robb; B L Innes; D L Birx; C G Hayes; S S Frankel
Journal:  Nat Med       Date:  2000-07       Impact factor: 53.440

7.  Human dendritic cells as targets of dengue virus infection.

Authors:  M Marovich; G Grouard-Vogel; M Louder; M Eller; W Sun; S J Wu; R Putvatana; G Murphy; B Tassaneetrithep; T Burgess; D Birx; C Hayes; S Schlesinger-Frankel; J Mascola
Journal:  J Investig Dermatol Symp Proc       Date:  2001-12

8.  Determination of tumor necrosis factor-alpha levels in dengue virus infected patients by sensitive biotin-streptavidin enzyme-linked immunosorbent assay.

Authors:  L Kittigul; W Temprom; D Sujirarat; C Kittigul
Journal:  J Virol Methods       Date:  2000-10       Impact factor: 2.014

9.  Dengue-specific T cell responses in peripheral blood mononuclear cells obtained prior to secondary dengue virus infections in Thai schoolchildren.

Authors:  Marlou M Mangada; Timothy P Endy; Ananda Nisalak; Supamit Chunsuttiwat; David W Vaughn; Daniel H Libraty; Sharone Green; Francis A Ennis; Alan L Rothman
Journal:  J Infect Dis       Date:  2002-05-31       Impact factor: 5.226

10.  Nonstructural 5A protein of hepatitis C virus modulates tumor necrosis factor alpha-stimulated nuclear factor kappa B activation.

Authors:  Kyu-Jin Park; Soo-Ho Choi; Soo Young Lee; Soon B Hwang; Michael M C Lai
Journal:  J Biol Chem       Date:  2002-01-30       Impact factor: 5.157

View more
  21 in total

Review 1.  Functions of the 3' and 5' genome RNA regions of members of the genus Flavivirus.

Authors:  Margo A Brinton; Mausumi Basu
Journal:  Virus Res       Date:  2015-02-13       Impact factor: 3.303

2.  Effects of tumor necrosis factor on viral replication and pulmonary inflammation during acute mouse adenovirus type 1 respiratory infection.

Authors:  Krittika Pant; Adithya Chandrasekaran; Christine J Chang; Aditya Vageesh; Alexandra J Popkov; Jason B Weinberg
Journal:  Virology       Date:  2020-05-23       Impact factor: 3.616

3.  Oligomeric procyanidins stimulate innate antiviral immunity in dengue virus infected human PBMCs.

Authors:  Emily M Kimmel; Maria Jerome; Jeff Holderness; Deann Snyder; Sharon Kemoli; Mark A Jutila; Jodi F Hedges
Journal:  Antiviral Res       Date:  2011-03-01       Impact factor: 5.970

4.  Targeted delivery of small interfering RNA to human dendritic cells to suppress dengue virus infection and associated proinflammatory cytokine production.

Authors:  Sandesh Subramanya; Sang-Soo Kim; Sojan Abraham; Jiahong Yao; Mukesh Kumar; Priti Kumar; Viraga Haridas; Sang-Kyung Lee; Leonard D Shultz; Dale Greiner; Manjunath N; Premlata Shankar
Journal:  J Virol       Date:  2009-12-16       Impact factor: 5.103

5.  Dengue Virus Induces Increased Activity of the Complement Alternative Pathway in Infected Cells.

Authors:  Sheila Cabezas; Gustavo Bracho; Amanda L Aloia; Penelope J Adamson; Claudine S Bonder; Justine R Smith; David L Gordon; Jillian M Carr
Journal:  J Virol       Date:  2018-06-29       Impact factor: 5.103

6.  Tumor necrosis factor alpha protects against lethal West Nile virus infection by promoting trafficking of mononuclear leukocytes into the central nervous system.

Authors:  Bimmi Shrestha; Bo Zhang; Whitney E Purtha; Robyn S Klein; Michael S Diamond
Journal:  J Virol       Date:  2008-07-16       Impact factor: 5.103

7.  Dengue virus infection induces upregulation of GRP78, which acts to chaperone viral antigen production.

Authors:  S Wati; M-L Soo; P Zilm; P Li; A W Paton; C J Burrell; M Beard; J M Carr
Journal:  J Virol       Date:  2009-09-30       Impact factor: 5.103

8.  Zika Virus Infection of Human Iris Pigment Epithelial Cells.

Authors:  Feargal J Ryan; Jillian M Carr; João M Furtado; Yuefang Ma; Liam M Ashander; Milena Simões; Genevieve F Oliver; G Bracho Granado; Abby C Dawson; Michael Z Michael; Binoy Appukuttan; David J Lynn; Justine R Smith
Journal:  Front Immunol       Date:  2021-04-22       Impact factor: 7.561

9.  Both viremia and cytokine levels associate with the lack of severe disease in secondary dengue 1 infection among adult Chinese patients.

Authors:  Yangbo Tang; Zhihua Kou; Fuchun Zhang; Xian Yao; Shengyong Liu; Jingming Ma; Yusen Zhou; Wei Zhao; Xiaoping Tang; Xia Jin
Journal:  PLoS One       Date:  2010-12-29       Impact factor: 3.240

10.  Viperin is induced following dengue virus type-2 (DENV-2) infection and has anti-viral actions requiring the C-terminal end of viperin.

Authors:  Karla J Helbig; Jillian M Carr; Julie K Calvert; Satiya Wati; Jennifer N Clarke; Nicholas S Eyre; Sumudu K Narayana; Guillaume N Fiches; Erin M McCartney; Michael R Beard
Journal:  PLoS Negl Trop Dis       Date:  2013-04-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.